NHS reforms become law
March 28, 2012Sales and Marketing CCGs, Commissioning Board, Lansley, NHS, PCTs, QIPP, reforms
After 18 months of political wrangling and mass opposition, the government’s reform of the NHS in England has been passed …
Sanofi sets up cholesterol drug showdown with Amgen
March 27, 2012Research and Development, Sales and Marketing Amgen, BMS, LDL, Lipitor, Merck, Regeneron, Sanofi
Sanofi and Amgen have posted results for their new injectable cholesterol drugs within 24 hours of each other. Both drugs …
Pharma manufacturing news in brief
March 27, 2012Manufacturing and Production Apotex, Ei Inc, Oxford Pharmascience and Bend Research, PharmaForm
Apotex sues FDA, Ei expands its production facilities in North Carolina, plus new developments at PharmaForm, Oxford Pharmascience and Bend …
Merck KGaA manufacturing under scrutiny by FDA
March 27, 2012Manufacturing and Production FDA, Merck KGaA, Rebif, Violations, manufacturing
The US Food and Drug Administration has asked Merck KGaA to undertake a ‘comprehensive and global assessment’ of its manufacturing …
Risk register spells out NHS reform risks
March 27, 2012Sales and Marketing NHS reforms, commissioning, health bill, risk register
A leaked document that assesses problems with the government’s reform of the NHS has been published by the Guardian. The …
Teva launches generic Seroquel in UK
March 27, 2012Sales and Marketing AZ, NHS, Quetiapine, Seroquel, Teva
Teva has launched a generic version of the antipsychotic Seroquel on the same day AstraZeneca loses patent protection on its …
FDA warns against phthalate use in medicines
March 27, 2012Manufacturing and Production FDA, SUPAC, manufacturing, phthalates
The Food and Drug Administration has warned pharma companies not to use two phthalates as excipients in both biological products and drugs, …
Contract research news in brief
March 27, 2012Research and Development AMRI, Cetero, Kforce, Particle Sciences and QED Clinical Services, inVentiv Health
Cetero files for bankruptcy after FDA admonishments, AMRI shutters Hungarian facility and inVentiv Health buys Kforce; also updates from Particle …
UK government launches new dementia programme
March 26, 2012Medical Communications, Sales and Marketing Alzheimer's, Cameron, UK, dementia
The government has signalled its intention to boost dementia funding and awareness with its new ‘challenge on dementia’ campaign. In …
Mobile monitoring of asthma ‘no better’ than traditional methods
March 26, 2012Medical Communications BMJ, Mobile monitoring, apps, asthma, smartphone
Mobile phone monitoring of asthma is ‘more expensive and no better than paper monitoring’, says new research. Findings published in …
HPI strengthens healthcare and pharma presence with new hire
March 26, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
HPI has strengthened its presence in the healthcare and pharma sectors with the appointment of Marianne MacDonell. She will head …
UCB nominates new board members
March 26, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UCB, board members
UCB has nominated Harriet Edelman and Charles-Antoine Janssen to become new members of UCB’s board of directors. The new nominations …
NICE looking into unlicensed and off-label drug use
March 26, 2012Sales and Marketing DoH, NICE, off label, off-label, postcode, unlicensed
NICE is reviewing the use of off-label and unlicensed medicines across the NHS in England. This follows a pilot project …
Rare diseases – pharma’s new frontier
March 26, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, CAPS, McConaghie, rare diseases
The last ten years has seen our understanding of rare diseases move ahead rapidly, often thanks to greater understanding of …
Shire signs CNS disorders deal with Heptares
March 23, 2012Research and Development A2A, CNS, GPCR, Heptares, Shire
Shire is to develop and commercialise a novel adenosine A2A antagonist discovered by Heptares currently in pre-clinical development.UK-based Heptares discovers and …
High Court rules against Seroquel XR patent
March 23, 2012Sales and Marketing Accord, AstraZeneca, Sandoz, Seroquel, Teva
A British High Court has ruled that AstraZeneca’s patent on its new formulation of the antipsychotic Seroquel is invalid. Seroquel …
Zaicom appoints Dr Beverly Barr as its new director
March 23, 2012Business Services, Medical Communications, Sales and Marketing Beverly Barr, Zaicom
Zaicom International has appointed Dr Beverly Barr as its new director and board member. The UK-based med comms group said …
Early-stage research gains another funding boost
March 23, 2012Research and Development, Sales and Marketing GSK, Index Ventures, Janssen, R&D
GlaxoSmithKline and Janssen are among the key investors in a venture capital fund aimed solely at identifying promising pharma start-ups. …
Universal World Events Celebrates Business Wins
March 22, 2012Sales and Marketing
Universal WorldEvents is delighted to announce a number of recent business development successes in the first two months of 2012. The …
NICE starts new wave of quality standards
March 22, 2012Sales and Marketing Commissioning Board, Future Forum, NHS, NICE
NICE has been given 123 new quality standards to work on, and includes for the first time new standards for …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
